NH-Amundi HANARO Bio Korea Active ETF Units

NH-Amundi HANARO Bio Korea Active ETF Units is offered by NH-Amundi, a leading player in the field of passive investments.

The ETF is listed in KRW.

European investors may incur additional costs for currency exchange and transaction fees.

No, NH-Amundi HANARO Bio Korea Active ETF Units does not comply with the EU UCITS investor protection directives.

The P/E ratio of NH-Amundi HANARO Bio Korea Active ETF Units is 41.72.

NH-Amundi HANARO Bio Korea Active ETF Units is domiciled in KR.

The fund was launched on 11/26/2024.

The NH-Amundi HANARO Bio Korea Active ETF Units mainly invests in Healthcare companies.

The NAV of NH-Amundi HANARO Bio Korea Active ETF Units amounts to 17.12 B KRW.

The price-to-book ratio is 6.047.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.